ClinicalTrials.gov
ClinicalTrials.gov Menu

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01416428
Recruitment Status : Active, not recruiting
First Posted : August 15, 2011
Last Update Posted : May 15, 2018
Sponsor:
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : November 30, 2018
  Estimated Study Completion Date : November 30, 2018